MR BIOINVEST ApS: Financial statements 2020
CVR: 25942817
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
MR BIOINVEST ApS (CVR 25942817) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -82,507 and a net result of DKK -101,915 compared with DKK 2,864,640 the year before. Equity in the 2020 report amounted to DKK 22,991,590. The solvency ratio was 99.7%.
- Gross Profit
- DKK -82,507
- Profit/Loss
- DKK -101,915
- Equity
- DKK 22,991,590
- Total Assets
- DKK 23,054,708
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -83K | -102K | 23M | 0 |
| 2019 | - | -33K | 2.9M | 23.1M | 0 |
| 2018 | - | -63K | -1.4M | 20.2M | 0 |
| 2017 | - | -48K | 437K | 21.6M | 0 |
| 2016 | - | -5K | 18.8M | 21.2M | - |
Official annual report
How creditworthy is MR BIOINVEST ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
MR BIOINVEST ApS has published its annual report for 2019. Gross profit came to DKK -32,500, and the net result was DKK 2,864,640.
About MR BIOINVEST ApS
MR BIOINVEST ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2001. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Mads Aage Laustsen. The company is owned by Mads Aage Laustsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,875 and a net result of DKK 1,503,262 compared with DKK 1,669,196 the year before. Equity in the 2025 report amounted to DKK 28,217,549.